CellaVision

120.60 SEK

+0.67%

1,477 following

CEVI

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for CellaVision

P/E

Median 2019-2025

EV/S

Median 2019-2024

EV/EBIT

Median 2019-2024

Dividend yield

Median 2019-2025

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)319.50307.00325.20229.00212.00217.50157.20
Shares23.923.923.923.923.923.923.9
Market cap7,620.77,322.67,756.75,462.05,056.55,187.73,749.5
Enterprise value7,678.57,353.17,763.05,456.54,999.65,065.1-
EV/S16.615.613.78.57.47.0-
EV/EBITDA52.351.539.627.624.223.1-
EV/EBIT60.766.747.734.529.928.5-
P/E76.881.861.946.238.836.924.5
P/B21.8817.0414.288.517.066.364.22
P/S16.515.513.78.57.57.24.9
Dividend yield0.0 %0.2 %0.6 %0.9 %1.1 %1.2 %1.8 %
Equity ratio54.3 %64.3 %65.8 %72.0 %77.1 %80.6 %81.1 %
Gearing ratio45.9 %30.9 %25.2 %16.0 %9.0 %3.3 %2.9 %